loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Lomitapide Mesylate in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 171,409Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AEGERION PHARMACEUTICALS INC

02 3Aegerion Pharmaceuticals Ltd.

03 3Aegerion Solvay Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

lomitapidmesilat

Brand Name : Lojuxta

Dosage Form : HARD CAPSULES

Dosage Strength : 5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

lomitapidmesilat

Brand Name : Lojuxta

Dosage Form : HARD CAPSULES

Dosage Strength : 20 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

lomitapidmesilat

Brand Name : Lojuxta

Dosage Form : HARD CAPSULES

Dosage Strength : 10 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bms201038

Brand Name : Lojuxta Rigid

Dosage Form : Lomitapide 5Mg 28 Combined Oral Use

Dosage Strength : 28 cps rigid 5 mg bottle

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bms201038

Brand Name : Lojuxta Rigid

Dosage Form : Lomitapide 10Mg 28 Combined Oral Use

Dosage Strength : 28 cps rigid 10 mg vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bms201038

Brand Name : Lojuxta Rigid

Dosage Form : Lomitapide 20Mg 28 Combined Oral Use

Dosage Strength : 28 cps rigid 20 mg vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bms201038

Brand Name : Lojuxta

Dosage Form : Capsule, hard

Dosage Strength : 10 mg

Packaging : Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bms201038

Brand Name : Lojuxta

Dosage Form : Capsule, hard

Dosage Strength : 20 mg

Packaging : Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

Bms201038

Brand Name : Lojuxta

Dosage Form : Capsule, hard

Dosage Strength : 5 mg

Packaging : Box

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank